Gadobenate dimeglumine (BOPTA) enhanced MR imaging: Patterns of enhancement in normal liver and cirrhosis-Reference-Cited by-同舟云学术

Gadobenate dimeglumine (BOPTA) enhanced MR imaging: Patterns of enhancement in normal liver and cirrhosis

Published:1998-07 Issue:4 Volume:8 Page:862-867
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Manfredi Riccardo,Maresca Giulia,Baron Richard L.,De Franco Antonio,De Gaetano Anna Maria,Cotroneo Antonio R.,Pirovano Giampaolo,Spinazzi Alberto,Marano Pasquale

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Reference17 articles.

1. Soluble-type hepatobiliary contrast agents for MR imaging

2. Preclinical Profile of Gd-BOPTA A Liver-Specific MRI Contrast Agent

3. Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers.

4. Interim Results of Phase II Clinical Testing of Gadobenate Dimeglumine

5. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis;Diagnostics;2023-03-23

2. Liver enhancement during hepatobiliary phase after Gd-BOPTA administration: correlation with liver and renal function;European Radiology;2020-09-30

3. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI;Journal of Magnetic Resonance Imaging;2015-04-06

4. CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I. Development, Growth, and Spread: Key Pathologic and Imaging Aspects;Radiology;2014-09

5. MR Imaging in Cirrhosis and Hepatocellular Carcinoma;Magnetic Resonance Imaging Clinics of North America;2014-08